Publication | Open Access
Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent
27
Citations
19
References
2010
Year
CYT997 was well tolerated at doses that were associated with pharmacodynamic evidence of vascular disruption in tumours.
| Year | Citations | |
|---|---|---|
Page 1
Page 1